Her primary areas of investigation include Immunology, Internal medicine, Acquired immunodeficiency syndrome, Immunopathology and Viral load. Her work deals with themes such as Neutropenia and Combination therapy, which intersect with Immunology. The various areas that Jennifer F Hoy examines in her Internal medicine study include Lipodystrophy, Endocrinology, Surgery, Lipoatrophy and Stavudine.
Her work on Sida as part of general Acquired immunodeficiency syndrome research is frequently linked to Effects of sleep deprivation on cognitive performance, bridging the gap between disciplines. The concepts of her Immunopathology study are interwoven with issues in Viral disease and Immune system. Her studies in Viral load integrate themes in fields like Dementia, Pre-exposure prophylaxis and Risk factor.
Her primary scientific interests are in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Virology. Her Internal medicine study incorporates themes from Gastroenterology and Surgery. Her Immunology study frequently draws connections to adjacent fields such as Disease.
Her Disease research integrates issues from Pathogenesis and Intensive care medicine. Her biological study deals with issues like Cohort, which deal with fields such as Retrospective cohort study. Her Viral load research includes elements of Men who have sex with men and Antiretroviral therapy.
Jennifer F Hoy mainly investigates Internal medicine, Immunology, Viral load, Men who have sex with men and Acquired immunodeficiency syndrome. Her work investigates the relationship between Internal medicine and topics such as Gastroenterology that intersect with problems in Coronary artery disease. She interconnects Dyslipidemia, Disease, Pharmacotherapy, Post-exposure prophylaxis and Prospective cohort study in the investigation of issues within Immunology.
Her study in Viral load is interdisciplinary in nature, drawing from both Treatment as prevention, Antiretroviral therapy and Health care. Her Men who have sex with men research incorporates elements of Cohort study, Reproductive health, Anal cancer, Family medicine and Gynecology. She works mostly in the field of Acquired immunodeficiency syndrome, limiting it down to concerns involving Cohort and, occasionally, Epidemiology and Transmission.
Jennifer F Hoy mainly focuses on Internal medicine, Antiretroviral therapy, Pre-exposure prophylaxis, Viral load and Men who have sex with men. Her research investigates the link between Internal medicine and topics such as Surgery that cross with problems in Art initiation, Clinical trial and Efavirenz. Her Pre-exposure prophylaxis research is multidisciplinary, relying on both Integrase inhibitor, Incidence and Intensive care medicine.
Her studies examine the connections between Incidence and genetics, as well as such issues in Acquired immunodeficiency syndrome, with regards to Logistic regression, T cell, Circulating MicroRNA, Case-control study and microRNA. Viral load is a subfield of Immunology that Jennifer F Hoy studies. Many of her studies involve connections with topics such as Population study and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
CD4+ count-guided interruption of antiretroviral treatment.
Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin.
The New England Journal of Medicine (2006)
Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel
Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio.
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel
Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy.
Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.
S M Crowe;J B Carlin;K I Stewart;C R Lucas.
Journal of Acquired Immune Deficiency Syndromes (1991)
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.
Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim.
PLOS Pathogens (2014)
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
Andrew Carr;Cassy Workman;Don E. Smith;Jennifer Hoy.
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.
Allison Martin;Don E Smith;Andrew Carr;Clare Ringland.
New spectrum of fungal infections in patients with cancer.
Elias Anaissie;Gerald P. Bodey;Hagop M Kantarjian;Jae Ro.
Clinical Infectious Diseases (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: